Literature DB >> 15607299

Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy.

C Neill Epperson1, Stephanie O'Malley, Kathryn A Czarkowski, Ralitza Gueorguieva, Peter Jatlow, Gerard Sanacora, Douglas L Rothman, John H Krystal, Graeme F Mason.   

Abstract

BACKGROUND: Given that nicotine modulates amino acid neurotransmission, we sought to examine the impact of nicotine on cortical gamma-aminobutyric acid (GABA) levels in male and female smokers.
METHODS: Healthy nicotine-dependent men (n = 10) and women (n = 6) underwent proton magnetic resonance spectroscopy (1H-MRS) to measure occipital cortex GABA concentrations. A subset of the smoking men (n = 5) underwent 1H-MRS scans before and after 48 hours of smoking abstinence, whereas each of the women were scheduled to undergo pre- and postabstinence scans during the follicular and luteal phases of one menstrual cycle. Healthy nonsmoking men (n = 7) and women (n = 13) underwent 1H-MRS for comparison.
RESULTS: Short-term abstinence had no significant effect on cortical GABA concentrations in either men or women. There was, however, a significant effect of sex, diagnosis (smoker/nonsmoker), and menstrual cycle phase on cortical GABA levels, such that female smokers experienced a significant reduction in cortical GABA levels during the follicular phase and no cyclicity in GABA levels across the menstrual cycle, whereas cortical GABA levels were similar in smoking and nonsmoking men.
CONCLUSIONS: Taken together with previous 1H-MRS data showing abnormalities in occipital cortex GABA concentrations in several affective disorders, our preliminary finding that nicotine modulation of GABA levels varies by sex provides a further rationale for investigating the impact of nicotine on central GABAergic function as a potential risk factor for women to experience depressive symptoms during smoking cessation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607299      PMCID: PMC4097033          DOI: 10.1016/j.biopsych.2004.09.021

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  27 in total

1.  Spectroscopic imaging of the uptake kinetics of human brain ethanol.

Authors:  H P Hetherington; F Telang; J W Pan; M Sammi; D Schuhlein; P Molina; N D Volkow
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

Review 2.  Neurosteroids: biochemistry and clinical significance.

Authors:  Synthia H Mellon; Lisa D Griffin
Journal:  Trends Endocrinol Metab       Date:  2002 Jan-Feb       Impact factor: 12.015

3.  Onset of major depression during treatment for nicotine dependence.

Authors:  Joel D Killen; Stephen P Fortmann; Alan Schatzberg; Chris Hayward; Ann Varady
Journal:  Addict Behav       Date:  2003-04       Impact factor: 3.913

4.  GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid.

Authors:  S S Smith; Q H Gong; F C Hsu; R S Markowitz; J M ffrench-Mullen; X Li
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

5.  Cerebral effects of nicotine during cognition in smokers and non-smokers.

Authors:  P H Ghatan; M Ingvar; L Eriksson; S Stone-Elander; M Serrander; K Ekberg; J Wahren
Journal:  Psychopharmacology (Berl)       Date:  1998-03       Impact factor: 4.530

6.  Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder.

Authors:  Andrew W Goddard; Graeme F Mason; Michael Appel; Douglas L Rothman; Ralitza Gueorguieva; Kevin L Behar; John H Krystal
Journal:  Am J Psychiatry       Date:  2004-12       Impact factor: 18.112

7.  Emergence of depression during early abstinence in depressed and non-depressed women smokers.

Authors:  C S Pomerleau; R J Brouwer; O F Pomerleau
Journal:  J Addict Dis       Date:  2001

8.  Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies.

Authors:  R P Irwin; S Z Lin; M A Rogawski; R H Purdy; S M Paul
Journal:  J Pharmacol Exp Ther       Date:  1994-11       Impact factor: 4.030

Review 9.  Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications.

Authors:  K Fuxe; K Andersson; P Eneroth; A Härfstrand; L F Agnati
Journal:  Psychoneuroendocrinology       Date:  1989       Impact factor: 4.905

10.  Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.

Authors:  C Neill Epperson; Kristin Haga; Graeme F Mason; Edward Sellers; Ralitza Gueorguieva; Wenjiang Zhang; Erica Weiss; Douglas L Rothman; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2002-09
View more
  56 in total

Review 1.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

2.  Genetic association of ErbB4 and human cortical GABA levels in vivo.

Authors:  Stefano Marenco; Matthew Geramita; Jan Willem van der Veen; Alan S Barnett; Bhaskar Kolachana; Jun Shen; Daniel R Weinberger; Amanda J Law
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

3.  Measurement of variation in the human cerebral GABA level by in vivo MEGA-editing proton MR spectroscopy using a clinical 3 T instrument and its dependence on brain region and the female menstrual cycle.

Authors:  Masafumi Harada; Hitoshi Kubo; Ayumi Nose; Hiromu Nishitani; Tsuyoshi Matsuda
Journal:  Hum Brain Mapp       Date:  2011-05       Impact factor: 5.038

4.  Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?

Authors:  David T Plante; J Eric Jensen; Laura Schoerning; John W Winkelman
Journal:  Neuropsychopharmacology       Date:  2012-02-08       Impact factor: 7.853

Review 5.  Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?

Authors:  Hildegard M Schuller
Journal:  Nat Rev Cancer       Date:  2009-02-05       Impact factor: 60.716

6.  Chronic cigarette smoking and heavy drinking in human immunodeficiency virus: consequences for neurocognition and brain morphology.

Authors:  Timothy C Durazzo; Johannes C Rothlind; Valerie A Cardenas; Colin Studholme; Michael W Weiner; Dieter J Meyerhoff
Journal:  Alcohol       Date:  2007-10-17       Impact factor: 2.405

7.  Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition.

Authors:  Marisa M Silveri; Jennifer T Sneider; David J Crowley; Michael J Covell; Deepa Acharya; Isabelle M Rosso; J Eric Jensen
Journal:  Biol Psychiatry       Date:  2013-03-14       Impact factor: 13.382

8.  Trajectories of cigarette smoking in adulthood predict insomnia among women in late mid-life.

Authors:  David W Brook; Elizabeth Rubenstone; Chenshu Zhang; Judith S Brook
Journal:  Sleep Med       Date:  2012-08-15       Impact factor: 3.492

Review 9.  The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature.

Authors:  Tracy Hellem; Xianfeng Shi; Gwen Latendresse; Perry F Renshaw
Journal:  J Am Psychiatr Nurses Assoc       Date:  2015 Jul-Aug       Impact factor: 2.385

10.  Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients.

Authors:  L Elliot Hong; Ikwunga Wonodi; Jada Lewis; Gunvant K Thaker
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.